WebBioPharmaSpec is a US and UK-based CRO, specializing in the structural and physicochemical characterization of biopharmaceuticals. Our technical expertise … Case Studies - BioPharmaSpec Blog - BioPharmaSpec News and Events - BioPharmaSpec Knowledge Center - BioPharmaSpec Biosimilars - BioPharmaSpec BioPharmaSpec provides a one-stop-shop service for structural and … BioPharmaSpec scientists use state-of-the-art instrumentation and technical … BioPharmaSpec scientists are skilled in the analysis and interpretation of free … PEGylated Proteins - BioPharmaSpec WebDec 2, 2016 · Clostridium difficile is the principal cause of nosocomial infectious diarrhea worldwide. The pathogen modifies its flagellin with either a type A or type B O-linked glycosylation system, which has a contributory role in pathogenesis. We study the functional role of glycosyltransferases modifying ty …
Theresa Schmidt - Graduate Scientist - BioPharmaSpec LinkedIn
WebBioPharmaSpec 1,202 followers on LinkedIn. Structural, physicochemical and biophysical protein characterization BioPharmaSpec is a UK and US based CRO providing structural and physicochemical protein characterization services. We help our clients get their biopharmaceutical products into clinical trials more cost effectively and quickly. Our … Webwww.biopharmaspec.com BioPharmaSpec Limited, Suite 3.1 Lido Medical Centre, St. Saviours Road, St. Saviour, Jersey JE2 7LA T: UK (0) 1534 483493 • F: UK (0) 1534 483494 • E: [email protected] Company Registration number: 99427 4 such, this form of quantitative analysis will only provide a basic level of quantitation. This may be interval international london office
Structural characterization methods for biosimilars: fit-for-purpose ...
WebMar 8, 2024 · The BioPharmaSpec Approach. BioPharmaSpec has developed a service for MS based HCP detection and quantitation as a support to HCP-ELISA assays. The service is set up as a phased approach with each ... WebBioPharmaSpec provides a one-stop-shop service for structural and physicochemical biopharmaceutical characterization requirements WebLiked by MJ O'CONNOR. A successful first day at BIO 2024. If you're attending Wednesday or Thursday, stop by booth 517 to say hello. Liked by MJ O'CONNOR. We are fighting fit for #BIO2024 in Philadelphia! Vikram S Shekhawat and Richard Easton will be at BioPharmaSpec Booth #517 until the bell has…. Liked by MJ O'CONNOR. interval international member log in